Évaluation de la pratique de l’amniocentèse sur le réseau sud-ouest francilien pendant l’année 2003

[1]  R. Frydman,et al.  Fear of Pregnancy Loss and Fetal Karyotyping: A Place for Third-Trimester Amniocentesis? , 2007, Fetal Diagnosis and Therapy.

[2]  F. Malone,et al.  Pregnancy Loss Rates After Midtrimester Amniocentesis , 2006, Obstetrics and gynecology.

[3]  D. Sahota,et al.  Risk factors for procedure‐related fetal losses after mid‐trimester genetic amniocentesis , 2006, Prenatal diagnosis.

[4]  A. Caughey,et al.  Chorionic Villus Sampling Compared With Amniocentesis and the Difference in the Rate of Pregnancy Loss , 2006, Obstetrics and gynecology.

[5]  J. Pezzullo,et al.  Risk of third-trimester amniocentesis: a case-control study. , 2006, American journal of perinatology.

[6]  M. Muhcu,et al.  Pregnancy outcome following second-trimester amniocentesis: a case-control study. , 2006, American journal of perinatology.

[7]  B. Brambati,et al.  Chorionic villus sampling and amniocentesis , 2005, Current opinion in obstetrics & gynecology.

[8]  O. Axelsson,et al.  Infant morbidity following amniocentesis and chorionic villus sampling for prenatal karyotyping , 2005, BJOG: an International Journal of Obstetrics and Gynaecology.

[9]  J. Seeds Diagnostic mid trimester amniocentesis: how safe? , 2004, American journal of obstetrics and gynecology.

[10]  O. Gómez-Marín,et al.  Genetic Amniocentesis Complications: Is the Incidence Overrated? , 2004, Gynecologic and Obstetric Investigation.

[11]  J. Philip,et al.  Late First-Trimester Invasive Prenatal Diagnosis: Results of an International Randomized Trial , 2004, Obstetrics and gynecology.

[12]  A. Thelin,et al.  Early Amniocentesis and Congenital Foot Deformities , 2002, Fetal Diagnosis and Therapy.

[13]  Y. Ville,et al.  Down's syndrome screening with nuchal translucency at 12(+0)-14(+0) weeks and maternal serum markers at 14(+1)-17(+0) weeks: a prospective study. , 2002, Human reproduction.

[14]  W. Barth,et al.  Complications of Third‐Trimester Amniocentesis Using Continuous Ultrasound Guidance , 2002, Obstetrics and gynecology.

[15]  R. Frydman,et al.  Is Routine Amniocentesis for Advanced Maternal Age Still Indicated? , 2001, Fetal Diagnosis and Therapy.

[16]  E. Ogris,et al.  Sequential screening for trisomy 21 by nuchal translucency measurement in the first trimester and maternal serum biochemistry in the second trimester in a low‐risk population , 2001, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[17]  R. Frydman,et al.  Screening for Down syndrome using first‐trimester ultrasound and second‐trimester maternal serum markers in a low‐risk population: a prospective longitudinal study , 2001, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[18]  A. Zejli,et al.  [Amniotic fluid leakage and premature rupture of membranes after amniocentesis. A review of the literature]. , 2000, Journal de gynecologie, obstetrique et biologie de la reproduction.

[19]  N. Papantoniou,et al.  Genetic amniocentesis in women 20–34 years old: associated risks , 2000, Prenatal diagnosis.

[20]  N. Okun,et al.  Technical factors in early amniocentesis predict adverse outcome. Results of the Canadian early (EA) versus mid‐trimester (MA) amniocentesis trial , 1999, Prenatal Diagnosis.

[21]  N. Nevin,et al.  Early amniocentesis: effect of removing a reduced volume of amniotic fluid on pregnancy outcome , 1998, Prenatal diagnosis.

[22]  C. Lundsteen,et al.  Randomised study of risk of fetal loss related to early amniocentesis versus chorionic villus sampling , 1997, The Lancet.

[23]  M. Hammar,et al.  Transplacental needle passage and other risk‐factors associated with second trimester amniocentesis , 1997, Acta obstetricia et gynecologica Scandinavica.

[24]  B. Eiben,et al.  On the complication risk of early amniocentesis versus standard amniocentesis. , 1997, Fetal diagnosis and therapy.

[25]  R. O. Davis,et al.  Pregnancy Outcome Following Genetic Amniocentesis at 11–14 Versus 16–19 Weeks' Gestation , 1996, Obstetrics and gynecology.

[26]  A. Bombard,et al.  Procedure-related fetal losses in transplacental versus nontransplacental genetic amniocentesis. , 1995, American journal of obstetrics and gynecology.

[27]  K. Nicolaides,et al.  Comparison of chorionic villus sampling and amniocentesis for fetal karyotyping at 10-13 weeks' gestation , 1994, The Lancet.

[28]  C. Trujillo,et al.  Prospective study of amniocentesis performed between weeks 9 and 16 of gestation: its feasibility, risks, complications and use in early genetic prenatal diagnosis. , 1990, American journal of medical genetics.

[29]  Ann Tabor,et al.  RANDOMISED CONTROLLED TRIAL OF GENETIC AMNIOCENTESIS IN 4606 LOW-RISK WOMEN , 1986, The Lancet.